FN2 Earnings Intelligence
Henry Schein (HSIC) earnings history
Henry Schein, Inc. (HSIC) quarterly earnings scorecards, market reactions, transcript intelligence, and historical context.
Earnings History
Henry Schein, Inc.
The Q2 analysis supports a constructive but conditional view of Henry Schein's operating trajectory: technology adoption, own-brand products, DSO consolidation, and value-creation initiatives are strengthening the growth mix. The case depends on sustaining margin gains and demand while managing foreign exchange, remeasurement effects, and softer diagnostic or equipment trends.
Henry Schein, Inc.
Henry Schein's Q1 FY2026 results demonstrate execution across multiple levers: 6.3% revenue growth led by U.S. dental and global technology, non-GAAP operating margin expansion to 7.53% from early value-creation benefits, and a strategic S.I.N. 360 acquisition deepening the implant portfolio. The 10% EPS beat and reaffirmed full-year guidance reflect management confidence in the path toward over $200M of operating-income improvement. Key watch items include margin sustainability amid rising freight costs, a light flu season dampening diagnostics demand, and the cadence of implant growth as the value-versus-premium mix evolves.
Henry Schein, Inc.
The quarter supports a constructive but execution-dependent view: demand in dental equipment and specialty implants was strong, while the maintained outlook and planned operating-income improvement leave progress on margins, implementation, and medical volumes as the key tests.
Henry Schein, Inc.
The quarter provides evidence supporting a constructive operating trajectory: sales growth, margin expansion, raised EPS guidance, and identifiable software, e-commerce, and efficiency initiatives. The case still depends on execution and on whether one-time gains and planned operating-income improvements translate into durable results.
Henry Schein, Inc.
The quarter supports a mixed thesis: demand and higher-margin businesses were resilient, but glove pricing, tariffs, restructuring execution, and orthodontic weakness remain material offsets.
Henry Schein, Inc.
The supplied analysis supports a balanced view: Henry Schein is showing operational improvement and broader contribution from higher-growth businesses, but the near-term revenue outlook is modest and execution, pricing and market risks remain material.
Get the HSIC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.